202 related articles for article (PubMed ID: 23001705)
41. Molecular profile of parathyroid tissues and tumours: a heterogeneous landscape.
Uljanovs R; Strumfa I; Bahs G; Vidusa L; Merkurjeva K; Franckevica I; Strumfs B
Pol J Pathol; 2021; 72(2):99-116. PubMed ID: 34706517
[TBL] [Abstract][Full Text] [Related]
42. Parathyroid Carcinoma: Diagnosis and Clinical Implications.
Duan K; Mete Ö
Turk Patoloji Derg; 2015; 31 Suppl 1():80-97. PubMed ID: 26177319
[TBL] [Abstract][Full Text] [Related]
43. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
44. Expressions of cell-cycle regulatory gene products in conventional gastric adenomas: possible immunohistochemical markers of malignant transformation.
Oya M; Yao T; Tsuneyoshi M
Hum Pathol; 2000 Mar; 31(3):279-87. PubMed ID: 10746668
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT.
Pyo JS; Cho WJ
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30926677
[TBL] [Abstract][Full Text] [Related]
46. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
47. Sonic hedgehog signaling pathway in Myelodysplastic Syndrome: Abnormal activation and jervine intervention.
Qin Y; Jiang M; Tuerxung N; Wang H; Zhao F; Zhen Y; Hao J
Gene; 2020 Sep; 754():144881. PubMed ID: 32526259
[TBL] [Abstract][Full Text] [Related]
48. Sonic hedgehog signaling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma.
Liu MS; Yang PY; Yeh TS
Pancreas; 2007 Apr; 34(3):340-6. PubMed ID: 17414057
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
Ikeda S; Ishizaki Y; Shimizu Y; Fujimori M; Ojima Y; Okajima M; Sugino K; Asahara T
Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
[TBL] [Abstract][Full Text] [Related]
50. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
51. Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas.
Kruijff S; Sidhu SB; Sywak MS; Gill AJ; Delbridge LW
Ann Surg Oncol; 2014 Feb; 21(2):426-33. PubMed ID: 24081804
[TBL] [Abstract][Full Text] [Related]
52. Activation of sonic hedgehog signaling in oral squamous cell carcinomas: a preliminary study.
Cavicchioli Buim ME; Gurgel CA; Gonçalves Ramos EA; Lourenço SV; Soares FA
Hum Pathol; 2011 Oct; 42(10):1484-90. PubMed ID: 21496866
[TBL] [Abstract][Full Text] [Related]
53. C-myc expression in adrenocortical tumours.
Pennanen M; Hagström J; Heiskanen I; Sane T; Mustonen H; Arola J; Haglund C
J Clin Pathol; 2018 Feb; 71(2):129-134. PubMed ID: 28801349
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemistry in Diagnostic Parathyroid Pathology.
Erickson LA; Mete O
Endocr Pathol; 2018 Jun; 29(2):113-129. PubMed ID: 29626276
[TBL] [Abstract][Full Text] [Related]
55. Role of calcium-sensing receptor, Galectin-3, Cyclin D1, and Ki-67 immunohistochemistry to favor in the diagnosis of parathyroid carcinoma.
Sungu N; Dogan HT; Kiliçarslan A; Kiliç M; Polat S; Tokaç M; Akbaba S; Parlak Ö; Balci S; Ögüt B; Çakir B
Indian J Pathol Microbiol; 2018; 61(1):22-26. PubMed ID: 29567879
[TBL] [Abstract][Full Text] [Related]
56. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
Endocr Relat Cancer; 2007 Jun; 14(2):501-12. PubMed ID: 17639063
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.
Schneider R; Bartsch-Herzog S; Ramaswamy A; Bartsch DK; Karakas E
World J Surg; 2015 Oct; 39(10):2477-83. PubMed ID: 26154578
[TBL] [Abstract][Full Text] [Related]
58. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.
Gill AJ; Lim G; Cheung VKY; Andrici J; Perry-Keene JL; Paik J; Sioson L; Clarkson A; Sheen A; Luxford C; Elston MS; Meyer-Rochow GY; Nano MT; Kruijff S; Engelsman AF; Sywak M; Sidhu SB; Delbridge LW; Robinson BG; Marsh DJ; Toon CW; Chou A; Clifton-Bligh RJ
Am J Surg Pathol; 2019 Jan; 43(1):35-46. PubMed ID: 29324469
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.
Uljanovs R; Sinkarevs S; Strumfs B; Vidusa L; Merkurjeva K; Strumfa I
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805976
[TBL] [Abstract][Full Text] [Related]
60. Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors.
Szijan I; Orlow I; Dalamon V; Vergani P; Danilowicz K; Mezzadri N; Cordon-Cardo C; Bruno OD
Oncol Rep; 2000; 7(2):421-5. PubMed ID: 10671696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
